CINECA IRIS Institutional Research Information System

CAPPELLO, EMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.173
AS - Asia 1.283
EU - Europa 964
SA - Sud America 185
AF - Africa 84
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.119
SG - Singapore 439
IT - Italia 294
CN - Cina 280
SE - Svezia 160
HK - Hong Kong 158
BR - Brasile 143
VN - Vietnam 106
IN - India 104
DE - Germania 101
GB - Regno Unito 90
FI - Finlandia 75
FR - Francia 63
JP - Giappone 53
NL - Olanda 44
CI - Costa d'Avorio 32
BG - Bulgaria 28
CA - Canada 26
TR - Turchia 24
KR - Corea 21
PL - Polonia 19
RU - Federazione Russa 19
AU - Australia 17
AT - Austria 15
MX - Messico 15
BD - Bangladesh 14
SN - Senegal 13
AR - Argentina 12
ID - Indonesia 12
IQ - Iraq 9
IR - Iran 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
LT - Lituania 8
NG - Nigeria 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
PK - Pakistan 7
EC - Ecuador 6
ES - Italia 6
MA - Marocco 6
PE - Perù 6
EG - Egitto 5
JO - Giordania 5
UA - Ucraina 5
VE - Venezuela 5
CL - Cile 4
JM - Giamaica 4
XK - ???statistics.table.value.countryCode.XK??? 4
AZ - Azerbaigian 3
CH - Svizzera 3
CO - Colombia 3
DK - Danimarca 3
DZ - Algeria 3
IE - Irlanda 3
IL - Israele 3
LV - Lettonia 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BE - Belgio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GH - Ghana 2
GR - Grecia 2
KZ - Kazakistan 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JE - Jersey 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SO - Somalia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 4.710
Salva come PNG Salva come JPEG
Città #
Ashburn 252
Singapore 246
San Jose 163
Hong Kong 154
Santa Clara 148
Dallas 144
Shanghai 92
Munich 56
Boardman 55
Los Angeles 55
Florence 47
Chandler 45
Beijing 42
New York 42
Helsinki 38
Pisa 37
Tokyo 37
London 36
Abidjan 32
Hanoi 30
Sofia 28
Turku 28
Ho Chi Minh City 27
Serra 27
Mumbai 25
Kent 21
Lauterbourg 19
Massa 19
Hyderabad 17
Princeton 17
Council Bluffs 16
Fairfield 16
Frankfurt am Main 16
Istanbul 16
Buffalo 13
Dakar 13
Lawrence 13
Phoenix 13
Chicago 12
Houston 12
Rome 12
San Francisco 12
Warsaw 12
Atlanta 11
Brooklyn 11
Da Nang 11
Denver 11
Hefei 11
Medford 10
Amsterdam 9
Milan 9
Ogden 9
Orem 9
Redondo Beach 9
Wilmington 9
Fuzhou 8
Lagos 8
Mexico City 8
São Paulo 8
Tashkent 8
Washington 8
Bengaluru 7
Chennai 7
Jakarta 7
Johannesburg 7
Nuremberg 7
Baltimore 6
Jeju City 6
Lappeenranta 6
Miami 6
Montreal 6
Rio de Janeiro 6
Roubaix 6
Seoul 6
Vienna 6
Amman 5
Belo Horizonte 5
Birmingham 5
Cambridge 5
Detroit 5
Düsseldorf 5
Livorno 5
Manchester 5
Marseille 5
New Malden 5
Paris 5
Philadelphia 5
Poplar 5
Prague 5
Quanzhou 5
The Bronx 5
Trujillo 5
Vancouver 5
Buenos Aires 4
Cascina 4
Curitiba 4
Haiphong 4
Kolkata 4
Melbourne 4
Memphis 4
Totale 2.529
Salva come PNG Salva come JPEG
Nome #
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 839
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 198
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 178
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 159
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 150
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 147
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 146
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 142
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 138
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 135
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 133
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 131
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 130
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 128
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 128
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 127
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 122
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 118
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 111
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 110
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 110
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 107
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 96
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use 94
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 94
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 89
Communicating Drug Safety 88
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 86
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 80
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 79
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 77
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 73
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database 70
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall 65
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 59
Pharmacological Phase I Clinical Trials in Pediatric Brain Tumors (1990–2024): A Historical Perspective 27
Totale 4.764
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 0 0 22
2021/2022279 4 2 39 51 48 22 13 10 13 8 20 49
2022/2023318 50 71 26 12 16 22 17 4 66 0 34 0
2023/2024379 2 9 19 3 28 41 51 36 32 25 66 67
2024/20251.452 26 58 85 118 91 145 142 55 145 159 173 255
2025/20262.308 147 114 180 182 195 95 260 58 148 156 738 35
Totale 4.764